Arbutus Biopharma News

Jefferies Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Raises Target Price to $7

Moomoo NewsSep 5 15:32 ET

Buy Rating Affirmed for Arbutus Biopharma Amid Positive Legal and Clinical Developments

TipRanksSep 5 15:10 ET

Arbutus Biopharma Analyst Ratings

BenzingaAug 2 13:55 ET

H.C. Wainwright Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsAug 2 06:36 ET

Chardan Capital Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsAug 1 22:32 ET

Buy Rating Justified by Arbutus Biopharma's Strong Financials and Focused Clinical Strategy

TipRanksAug 1 22:17 ET

JMP Securities Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Raises Target Price to $5

Moomoo NewsAug 1 15:32 ET

Arbutus Biopharma: Strategic Focus and Pipeline Promise Drive Buy Rating

TipRanksAug 1 15:10 ET

Arbutus Biopharma Analyst Ratings

BenzingaJun 7 11:31 ET

Arbutus Biopharma Analyst Ratings

BenzingaJun 5 16:20 ET

Chardan Capital Maintains Buy on Arbutus Biopharma, Maintains $4 Price Target

BenzingaJun 5 16:20 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Hologic (HOLX) and Arbutus Biopharma (ABUS)

TipRanksMay 8 00:50 ET

Arbutus Biopharma Analyst Ratings

BenzingaMay 3 09:21 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Arbutus Biopharma (ABUS), Neurocrine (NBIX) and Bausch Health Companies (BHC)

TipRanksMay 3 07:15 ET

Analysts Are Bullish on Top Healthcare Stocks: Arbutus Biopharma (ABUS), Lemaitre Vascular (LMAT)

TipRanksMay 3 00:35 ET

Arbutus Biopharma Analyst Ratings

BenzingaApr 4 08:50 ET

Analysts Are Bullish on These Healthcare Stocks: Atossa Therapeutics (ATOS), Arbutus Biopharma (ABUS)

TipRanksApr 3 15:25 ET

Analysts Offer Insights on Healthcare Companies: Arbutus Biopharma (ABUS), Twist Bioscience (TWST) and Catalent (CTLT)

TipRanksMar 5 01:25 ET

Arbutus Biopharma Analyst Ratings

BenzingaMar 1 07:21 ET

Buy Rating Affirmed for Arbutus Biopharma on Strong Clinical Outlook and Litigation Prospects

TipRanksFeb 29 13:55 ET